Rentokil Initial Plc /Fi (RKLIF) EBIT (2021 - 2025)

Rentokil Initial (RKLIF) has reported EBIT for 4 consecutive years, with $511.0 million the latest figure, recorded in Q4 2025.

• In Q4 2025, EBIT changed N/A year-over-year to $511.0 million; the TTM figure through Dec 2025 stood at $1.5 billion (changed N/A YoY), while the FY2025 annual figure was $1.1 billion, up 51.85% from the prior year.
• EBIT rose to $511.0 million in Q4 2025 per RKLIF's latest filing, from -$230.0 million in the prior quarter.
• Across five years, EBIT topped out at $669.7 million in Q4 2022 and bottomed at -$230.0 million in Q3 2025.
• Historically, EBIT has averaged $417.8 million across 4 years, with a median of $542.4 million in 2023.
• Annual changes were most pronounced in 2022 — EBIT advanced 12.41% — and 2023, when it dropped 19.02%.
• Rentokil Initial's EBIT stood at $595.8 million in 2021, then grew by 12.41% to $669.7 million in 2022, then slipped by 19.02% to $542.4 million in 2023, then fell by 5.79% to $511.0 million in 2025.
• Business Quant data shows RKLIF's EBIT at $511.0 million in Q4 2025, -$230.0 million in Q3 2025, and $542.4 million in Q4 2023.